Gastrointestinal Eosinophilia

Immunology and Allergy Clinics of North America

Volumn 27, Issue 3, 2007, Pages 443-455

  Zuo, Li ^a   Rothenberg, Marc E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; BUDESONIDE; CARBAMAZEPINE; CLOFAZIMINE; COTRIMOXAZOLE; CROMOGLYCATE DISODIUM; CYTOKINE; ENALAPRIL; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PEROXIDASE; EOSINOPHIL PROTEIN X; GEMFIBROZIL; GLUCOCORTICOID; GOLD SALT; HYDROXYUREA; IMATINIB; IMMUNOGLOBULIN E ANTIBODY; INOSINATE DEHYDROGENASE INHIBITOR; INTERLEUKIN 5 ANTIBODY; KETOTIFEN; MAJOR BASIC PROTEIN; MERCAPTOPURINE; MONTELUKAST; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROTON PUMP INHIBITOR; RANTES; STEROID; SUPLATAST TOSYLATE;

CHROMOSOME 4; CHROMOSOME DELETION; CLINICAL FEATURE; CLINICAL TRIAL; DIET RESTRICTION; DIET THERAPY; DIETARY INTAKE; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILIC GASTROENTERITIS; EOSINOPHILIC GASTROINTESTINAL DISORDER; ESOPHAGUS BIOPSY; FECES ANALYSIS; FOOD ALLERGY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HUMAN; HYPEREOSINOPHILIC SYNDROME; MORBIDITY; NONHUMAN; PARASITOSIS; PATHOGENESIS; PHYSICAL EXAMINATION; PRICK TEST; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; REVIEW; SKIN TEST; TREATMENT DURATION;

CYTOKINES; EOSINOPHILIA; EOSINOPHILS; GASTROINTESTINAL DISEASES; HUMANS; HYPEREOSINOPHILIC SYNDROME;

EID: 34548569185     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2007.06.002     Document Type: Review

References (85)

1. Kato M., Kephart G.M., Talley N.J., et al. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 252 3 (1998) 418-425
2. Mishra A., Hogan S.P., Lee J.J., et al. Fundamental signals regulate eosinophil homing to the gastrointestinal tract. J Clin Invest 103 12 (1999) 1719-1727
3. Rothenberg M.E., Mishra A., Brandt E.B., et al. Gastrointestinal eosinophils. Immunol Rev 179 (2001) 139-155
4. Straumann A., Kristl J., Conus S., et al. Cytokine expression in healthy and inflamed mucosa: probing the role of eosinophils in the digestive tract. Inflamm Bowel Dis 11 8 (2005) 720-726
5. Gleich G.J., Frigas E., Loegering D.A., et al. Cytotoxic properties of the eosinophil major basic protein. J Immunol 123 6 (1979) 2925-2927
6. Gleich G.J., and Adolphson C.R. The eosinophilic leukocyte: structure and function. Adv Immunol 39 (1986) 177-253
7. Slifman N.R., Loegering D.A., McKean D.J., et al. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol 137 9 (1986) 2913-2917
8. Rosenberg H.F., Dyer K.D., Tiffany H.L., et al. Rapid evolution of a unique family of primate ribonuclease genes. Nat Genet 10 2 (1995) 219-223
9. Young J.D., Peterson C.G., Venge P., et al. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 321 6070 (1986) 613-616
10. Jacoby D.B., Gleich G.J., and Fryer A.D. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Invest 91 (1993) 1314-1318
11. Kita H. The eosinophil: a cytokine-producing cell?. J Allergy Clin Immunol 97 4 (1996) 889-892
12. Gharaee-Kermani M., and Phan S.H. The role of eosinophils in pulmonary fibrosis. Int J Mol Med 1 (1998) 43-53
13. Phipps S., Ying S., Wangoo A., et al. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol 169 8 (2002) 4604-4612
14. Lucey D.R., Nicholson W.A., and Weller P.F. Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci USA 86 4 (1989) 1348-1351
15. Lacy P., Levi-Schaffer F., Mahmudi-Azer S., et al. Intracellular localization of interleukin-6 in eosinophils from atopic asthmatics and effects of interferon gamma. Blood 91 7 (1998) 2508-2516
16. Shi H.Z., Humbles A., Gerard C., et al. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 105 7 (2000) 945-953
17. Mattes J., Yang M., Mahalingam S., et al. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med 195 11 (2002) 1433-1444
18. Lewis R.A., Austen K.F., and Soberman R.J. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 323 10 (1990) 645-655
19. Torpier G., Colombel J.F., Mathieu-Chandelier C., et al. Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin Exp Immunol 74 3 (1988) 404-408
20. Klein N.C., Hargrove R.L., Sleisenger M.H., et al. Eosinophilic gastroenteritis. Medicine 2 (1970) 215-225
21. Cello J.P. Eosinophil gastroenteritis: a complex disease entity. Am J Med 67 (1979) 1097-1114
22. Bischoff S., and Crowe S.E. Food allergy and the gastrointestinal tract. Curr Opin Gastroenterol 20 2 (2004) 156-161
23. Schappi M.G., Smith V.V., Milla P.J., et al. Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction. Gut 52 5 (2003) 752-755
24. Sawatzky D.A., Kingham P.J., Court E., et al. Eosinophil adhesion to cholinergic nerves via ICAM-1 and VCAM-1 and associated eosinophil degranulation. Am J Physiol Lung Cell Mol Physiol 282 6 (2002) L1279-88
25. Nie Z., Nelson C.S., Jacoby D.B., et al. Expression and regulation of intercellular adhesion molecule-1 on airway parasympathetic nerves. J Allergy Clin Immunol 119 6 (2007) 1415-1422
26. Noel R.J., Putnam P.E., Collins M.H., et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2 7 (2004) 568-575
27. Noel R.J., Putnam P.E., and Rothenberg M.E. Eosinophilic esophagitis. N Engl J Med 351 9 (2004) 940-941
28. Caldwell J.H., Tennerbaum J.I., and Bronstein H.A. Serum IgE to eosinophilic gastroenteritis. N Engl J Med 292 (1975) 1388-1390
29. Scudamore H.H., Phillips S.F., Swedlund H.A., et al. Food allergy manifested by eosinophilia, elevated immunoglobulin E level, and protein-losing enteropathy: the syndrome of allergic gastroenteropathy. J Allergy Clin Immunol 70 (1982) 129-136
30. Furuta G.T., Ackerman S.J., and Wershil B.K. The role of the eosinophil in gastrointestinal diseases. Curr Opin Gastroenterol 11 (1995) 541-547
31. Iacono G., Carroccio A., Cavataiio F., et al. Gastroesophageal reflux and cow's milk allergy in infants: a prospective study. J Allergy Clin Immunol 97 (1996) 822-827
32. Sampson H.A. Food allergy. JAMA 278 (1997) 1888-1894
33. Walsh S.V., Antonioli D.A., Goldman H., et al. Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol 23 4 (1999) 390-396
34. Spergel J., Rothenberg M.E., and Fogg M. Eliminating eosinophilic esophagitis. Clin Immunol 115 2 (2005) 131-132
35. Kelly K.J., Lazenby A.J., Rowe P.C., et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 109 5 (1995) 1503-1512
36. Oyaizu N., Uemura Y., Izumi H., et al. Eosinophilic gastroenteritis: immunohistochemical evidence for IgE mast cell-mediated allergy. Acta Pathol Jpn 35 (1985) 759-766
37. Bischoff S.C. Mucosal allergy: role of mast cells and eosinophil granulocytes in the gut. Baillieres Clin Gastroenterol 10 3 (1996) 443-459
38. Rothenberg M.E., Mishra A., Brandt E.B., et al. Gastrointestinal eosinophils in health and disease. Adv Immunol 78 (2001) 291-328
39. Sampson H.A. Food allergy. Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol 103 5 (1999) 717-728
40. Fox V.L., Nurko S., and Furuta G.T. Eosinophilic esophagitis: it's not just kid's stuff. Gastrointest Endosc 56 2 (2002) 260-270
41. Bates B. 'Explosion' of eosinophilic esophagitis in children. Pediatr News 34 (2000) 4
42. Croese J., Fairley S.K., Masson J.W., et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc 58 4 (2003) 516-522
43. Cury E.K., Schraibman V., and Faintuch S. Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children-discussion on daily practice. J Pediatr Surg 39 2 (2004) e4-e7
44. Attwood S.E., Smyrk T.C., Demeester T.R., et al. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 38 1 (1993) 109-116
45. Cantu P., Velio P., Prada A., et al. Ringed oesophagus and idiopathic eosinophilic oesophagitis in adults: an association in two cases. Dig Liver Dis 37 2 (2005) 129-134
46. Fujiwara H., Morita A., Kobayashi H., et al. Infiltrating eosinophils and eotaxin: their association with idiopathic eosinophilic esophagitis. Ann Allergy Asthma Immunol 89 4 (2002) 429-432
47. Munitiz V., Martinez de Haro L.F., Ortiz A., et al. Primary eosinophilic esophagitis. Dis Esophagus 16 2 (2003) 165-168
48. Lucendo Villarin A.J., Carrion Alonso G., Navarro Sanchez M., et al. Eosinophilic esophagitis in adults, an emerging cause of dysphagia. Description of 9 cases. Rev Esp Enferm Dig 97 4 (2005) 229-239
49. Straumann A., and Simon H.U. The physiological and pathophysiological roles of eosinophils in the gastrointestinal tract. Allergy 59 1 (2004) 15-25
50. Ruchelli E., Wenner W., Voytek T., et al. Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy. Pediatr Dev Pathol 2 1 (1999) 15-18
51. Liacouras C.A., and Ruchelli E. Eosinophilic esophagitis. Curr Opin Pediatr 16 (2004) 560-566
52. Walker N.I., Croese J., Clouston A.D., et al. Eosinophilic enteritis in northeastern Australia. Pathology, association with Ancylostoma caninum, and implications. Am J Surg Pathol 19 3 (1995) 328-337
53. Al Samman M., Haque S., and Long J.D. Strongyloidiasis colitis: a case report and review of the literature. J Clin Gastroenterol 28 1 (1999) 77-80
54. Assa'ad A.H., Putnam P.E., Collins M.H., et al. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol 119 3 (2007) 731-738
55. Straumann A., Spichtin H.P., Bucher K.A., et al. Eosinophilic esophagitis: red on microscopy, white on endoscopy. Digestion 70 2 (2004) 109-116
56. Lee J.H., Rhee P.L., Kim J.J., et al. The role of mucosal biopsy in the diagnosis of chronic diarrhea: value of multiple biopsies when colonoscopic finding is normal or nonspecific. Korean J Intern Med 12 2 (1997) 182-187
57. DeBrosse C.W., Case J.W., Putnam P.E., et al. Quantity and Distribution of Eosinophils in the Gastrointestinal Tract of Children. Pediatr Dev Pathol 9 (2006) 210-218
58. Guajardo J.R., Plotnick L.M., Fende J.M., et al. Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry. J Pediatr 141 4 (2002) 576-581
59. Lowichik A., and Weinberg A.G. A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract. Mod Pathol 9 2 (1996) 110-114
60. Ngo P., Furuta G.T., Antonioli D.A., et al. Eosinophils in the esophagus-peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 101 7 (2006) 1666-1670
61. Justinich C., Katz A., Gurbindo C., et al. Elemental diet improves steroid-dependent eosinophilic gastroenteritis and reverses growth failure. J Pediatr Gastroenterol Nutr 23 1 (1996) 81-85
62. Kelly K.J., Lazenby A.J., Rowe P.C., et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 109 5 (1995) 1503-1512
63. Foroughi S., and Prussin C. Clinical management of eosinophilic gastrointestinal disorders. Curr Allergy Asthma Rep 5 4 (2005) 259-261
64. Garrett J.K., Jameson S.C., Thomson B., et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 113 1 (2004) 115-119
65. Stein M.L., Collins M.H., Villanueva J.M., et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 118 6 (2006) 1312-1319
66. Anderson R.E., and Hardy W.R. Hypereosinophilia. Ann Intern Med 69 6 (1968) 1331-1332
67. Chusid M.J., Dale D.C., West B.C., et al. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54 1 (1975) 1-27
68. Roufosse F., Cogan E., and Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med 54 (2003) 169-184
69. Simon H.U., Plotz S.G., Dummer R., et al. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 341 15 (1999) 1112-1120
70. Cools J., DeAngelo D.J., Gotlib J., et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348 13 (2003) 1201-1214
71. Cortes J., Ault P., Koller C., et al. Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood 101 (2003) 4717-16
72. Schaller J.L., and Burkland G.A. Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate. Med Gen Med 3 5 (2001) 9
73. Ault P., Cortes J., Koller C., et al. Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate. Leuk Res 26 9 (2002) 881-884
74. Gleich G.J., Leiferman K.M., Pardanani A., et al. Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet 359 9317 (2002) 1577-1578
75. Griffin J.H., Leung J., Bruner R.J., et al. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci U S A 100 13 (2003) 7830-7835
76. Yamada Y., Rothenberg M.E., Lee A.W., et al. The FIP1L1-PDGFR{alpha} fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease. Blood 107 (2006) 4071-4079
77. Klion A.D., Noel P., Akin C., et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 101 12 (2003) 4660-4666
78. Klion A.D., Robyn J.A., Akin C., et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 101 (2003) 4660-4666
79. Yoshida T., Naganuma T., Niizawa M., et al. [A case of eosinophilic gastroenteritis accompanied by perimyocarditis, which was strongly suspected]. Nippon Shokakibyo Gakkai Zasshi 92 8 (1995) 1183-1188 [in Japanese]
80. Hussain A., Brown P.J., Thwaites B.C., et al. Eosinophilic endomyocardial disease due to high grade chest wall sarcoma. Thorax 49 10 (1994) 1040-1041
81. Andy J.J., Ogunowo P.O., Akpan N.A., et al. Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. Acta Trop 69 2 (1998) 127-140
82. Walsh R.E., and Gaginella T.S. The eosiniophil in inflammatory bowel disease. Scand J Gastroenterol 26 (1991) 1217-1224
83. Desreumaux P., Nutten S., and Colombel J.F. Activated eosinophils in inflammatory bowel disease: do they matter?. Am J Gastroenterol 94 12 (1999) 3396-3398
84. Nishitani H., Okabayashi M., Satomi M., et al. Infiltration of peroxidase-producing eosinophils into the lamina propria of patients with ulcerative colitis. J Gastroenterol 33 2 (1998) 189-195
85. Blanchard C., Wang N., and Rothenberg M.E. Eosinophilic esophagitis: pathogenesis, genetics, and therapy. J Allergy Clin Immunol 118 5 (2006) 1054-1059